High-Density Lipoproteins Protect Macrophage-Like Cells from Apoptosis Caused by Oxidized Low-Density Lipoproteins and TNF-α

被引：0

作者：

E. E. Larionova ^{[1
]}

A. D. Denisenko ^{[1
]}

机构：

[1] Institute of Experimental Medicine, St. Petersburg

来源：

Cell and Tissue Biology | 2024年 / 18卷 / 6期

关键词：

apoptosis; atherosclerosis; high-density lipoproteins; oxidized low-density lipoproteins;

D O I：

10.1134/S1990519X24700573

中图分类号：

学科分类号：

摘要：

Abstract: Apoptosis of various cells, primarily macrophages, in atherosclerotic arterial lesions is considered to be an important element in the pathogenesis of this disease. It is assumed that one of the main inducers of cell death in the intima of the affected arteries are oxidized low-density lipoproteins (oxLDLs). In this work, we studied the influence of high-density lipoproteins (HDLs), oxLDLs, and the TNF-α factor in different concentrations on macrophage-like cells obtained from mononuclear cells from the peripheral blood of healthy donors. It has been established that oxLDLs in small concentrations can cause the death of human macrophage-like cells after a short-term effect, which indicates their high cytotoxicity. HDLs in physiological concentrations completely block the processes of apoptosis caused by oxLDLs. It has been shown that HDLs are capable not only of protecting cells from oxLDLs, but also of significantly reducing the number of dead cells when exposed to TNF-α. The results obtained suggest that HDLs are capable of protecting cells from a wide range of cytotoxic agents. © Pleiades Publishing, Ltd. 2024. ISSN 1990-519X, Cell and Tissue Biology, 2024, Vol. 18, No. 6, pp. 671–679. Pleiades Publishing, Ltd., 2024.

引用

页码：671 / 679

页数：8

共 33 条

[1]

Assmann G., Gotto A.M., HDL cholesterol and protective factors in atherosclerosis, Circulation, 109, 1, (2004)

[2]

Bonizzi A., Piuri G., Corsi F., Cazzola R., Mazzucchelli S., HDL dysfunctionality: clinical relevance of quality rather than quantity, Biomedicines, 9, (2021)

[3]

Denisenko A.D., Makovejchuk E.G., Vinogradov A.G., Kuznetzov A.S., Klimov A.N., Autoantibodies against oxidized low density lipoproteins and lipoprotein-antibody autoimmune complexes in human atherosclerosis, Eur. J. Lab. Med, 4, (1996)

[4]

Fotakis P., Kothari V., Thomas D.G., Westerterp M., Molusky M.M., Altin E., Abramowicz S., Wang N., He Y., Heinecke J.W., Bornfeldt K.E., Tall A.R., Anti-inflammatory effects of HDL (high-density lipoprotein) in macrophages predominate over proinflammatory effects in atherosclerotic plaques, Arterioscler., Thromb., Vasc. Biol, 39, (2019)

[5]

Harada-Shiba M., Kinoshita M., Kamido H., Shimokado K., Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms, J. Biol. Chem, 273, (1998)

[6]

Havel R.J., Eder H.A., Bragdon J.H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest, 34, (1955)

[7]

Holvoet P., Van Cleemput J., Collen D., Vanhaecke J., Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease, Arterioscler., Thromb., Vasc. Biol, 20, (2000)

[8]

Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., Collen D., Muls E., Van De Werf F., Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease, Arterioscler., Thromb., Vasc. Biol, 21, (2001)

[9]

Kita T., Kume N., Minami M., Hayashida K., Murayama T., Sano H., Moriwaki H., Kataoka H., Nishi E., Horiuchi H., Arai H., Yokode M., Role of oxidized LDL in atherosclerosis, Ann. N. Y. Acad. Sci, 947, (2001)

[10]

Klimov A.N., Nikulcheva N.G., Obmen Lipidov I Lipoproteidov I Ego Narusheniya (Lipid and Lipoprotein Metabolism and Its Disorders), (1999)

← 1 2 3 4 →